Aripiprazole is mainly used for the treatment of schizophrenia. This drug can improve the affective disorder associated with schizophrenia and reduce the relapse rate of schizophrenia. It can also be used to treat manic episodes of bidirectional type I affective disorder, or the acute and maintenance phases of mixed episodes. In addition, aripiprazole can be used to treat psychiatric disorders such as irritability associated with autism, Tourette’s syndrome, and adjunctive treatment of major depressive disorder. The side effects of aripiprazole are minor, and a small number of patients may experience weight gain, extrapyramidal reactions such as headache, drowsiness, and urinary incontinence. Aripiprazole has a low effect on lactogen levels and does not affect the menstrual cycle, so women of childbearing age can also use this drug. It should be used with caution in women who are pregnant or breastfeeding, in patients with cardiovascular disease, in patients with a history of epilepsy, and in patients at risk of aspiration pneumonia. Since the brain of patients with schizophrenia may be damaged as the disease progresses, the application of aripiprazole in the treatment of schizophrenia may also serve to protect the brain to some extent. However, aripiprazole is a psychiatric medication, so it needs to be administered, reduced and discontinued with the help of a psychiatrist’s guidance to avoid serious consequences such as aggravation of symptoms or adverse reactions due to private administration or reduction and discontinuation of the medication.